

Recent Posts
- Aucentra Therapeutics appoints Dr David Fuller as Chief Medical Officer, commencing 16 November 2022
- Aucentra Therapeutics appoints Maria Maieli as Chief Financial Officer
- Prof. Shudong Wang Gives Pancreatic Cancer Research Webinar for UniSA
- Aucentra Therapeutics Appoints Joe Bayer as Chief Executive Officer
- Aucentra initiates its Phase 1a/b study of Auceliciclib in Glioblastoma Multiforme (GBM) patients in combination with Temozolomide
Recent Comments